Patent ID: 7329777

Claim:
A method for treating a cardiovascular disorder selected from the group consisting of heart failure and thromboembolic disorders, comprising administering an effective amount of a compound of formula (I) in which R 1 is located in the meta- or para-position to the radical W and represents a radical selected from the group consisting of H, halogen and OCF 3 ; R 2 represents H or halogen; R 3 represents H or halogen; R 4 represents C 1-6 -alkyl, C 3-8 -cycloalkyl, CF 3 , OCF 3 , F, Cl, OMe or phenyl, where the phenyl radical may additionally carry a substituent selected from the group consisting of halogen, CN, C 1-6 -alkoxy, CF 3 and C 1-6 -alkyl; V is located in the ortho- or meta-position to the radical W and represents O, CH 2 O, OCF 2 or O—C 1-6 -alkyl-O; and W represents CH 2 or CH 2 CH 2 ; or a pharmaceutically acceptable salt or stereoisomer thereof.